| Financial Year |
March 31 2023 |
| Monetary Funds |
1,316,214,777.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
34,340,415.19 |
| Advances to Suppliers |
448,626,412.84 |
| Other Receivables |
118,122,217.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,286,909.58 |
| Inventories |
923,380,278.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
91,496,760.03 |
| Total Current Assets |
2,937,893,047.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
44,114,401.61 |
| Investment Properties |
7,186,354.88 |
| Fixed Assetes |
199,497,139.76 |
| Under-construction Projects |
924,280.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,292,122.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
43,501,088.03 |
| Deferred Income Tax Assets |
5,471,376.85 |
| Other Non-Current Assets |
28,034,736.41 |
| Sub-Total of Non-Current Assets |
513,063,019.80 |
| Total Assets |
3,450,956,067.66 |
| Short-Term Loans |
94,825,102.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,633,703,318.00 |
| Accounts Payable |
8,375,208.34 |
| Accounts Received In Advance |
14,481,896.89 |
| Employee Compensation Payable |
50,399,082.42 |
| Taxes Payable |
27,781,216.61 |
| Interest Payable |
-- |
| Dividend Payable |
33,821.60 |
| Other payables |
66,442,839.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,144,012.48 |
| Other Current Liabilities |
15,389,114.60 |
| Sub-Total of Current Liabilities |
2,007,321,209.45 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
23,935,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,226,471.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
238,507,061.34 |
| Total Liabilities |
2,245,828,270.79 |
| Paid-In Capital(Or Share Stock) |
495,972,914.00 |
| Capital Surplus |
1,782,934,309.84 |
| Surplus Reserve |
53,165,313.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,184,205,590.98 |
| Minority Stockholder's Interest |
52,225,590.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,152,902,206.85 |
| Owner's Equity（Stockholder's Equity） |
1,205,127,796.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,450,956,067.66 |
